Hepatitis C reinfection after sustained virological response
H Midgard, B Bjøro, A Mæland, Z Konopski… - Journal of …, 2016 - Elsevier
Background & Aims On-going risk behaviour can lead to hepatitis C virus (HCV) reinfection
following successful treatment. We aimed to assess the incidence of persistent HCV
reinfection in a population of people who inject drugs (PWID) who had achieved sustained
virological response (SVR) seven years earlier. Methods In 2004–2006 we conducted a
multicentre treatment trial comprising HCV genotype 2 or 3 patients in Sweden, Norway and
Denmark (NORTH-C). Six months of abstinence from injecting drug use (IDU) was required …
following successful treatment. We aimed to assess the incidence of persistent HCV
reinfection in a population of people who inject drugs (PWID) who had achieved sustained
virological response (SVR) seven years earlier. Methods In 2004–2006 we conducted a
multicentre treatment trial comprising HCV genotype 2 or 3 patients in Sweden, Norway and
Denmark (NORTH-C). Six months of abstinence from injecting drug use (IDU) was required …
